Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $11.7 million.

  • Xtant Medical Holdings' Other Operating Expenses fell 121.11% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.2 million, marking a year-over-year decrease of 1236.38%. This contributed to the annual value of $49.2 million for FY2024, which is 123879.22% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Other Operating Expenses stood at $11.7 million for Q3 2025, which was down 121.11% from $11.6 million recorded in Q2 2025.
  • Xtant Medical Holdings' Other Operating Expenses' 5-year high stood at $15.2 million during Q4 2023, with a 5-year trough of -$20.0 million in Q4 2022.
  • For the 5-year period, Xtant Medical Holdings' Other Operating Expenses averaged around $4.8 million, with its median value being $5.3 million (2021).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first tumbled by 47701.86% in 2022, then soared by 65961.78% in 2024.
  • Over the past 5 years, Xtant Medical Holdings' Other Operating Expenses (Quarter) stood at $5.3 million in 2021, then crashed by 477.02% to -$20.0 million in 2022, then soared by 176.11% to $15.2 million in 2023, then fell by 23.36% to $11.7 million in 2024, then grew by 0.53% to $11.7 million in 2025.
  • Its last three reported values are $11.7 million in Q3 2025, $11.6 million for Q2 2025, and $11.2 million during Q1 2025.